Ageno W, Bertu L, Bucherini E, Camporese G, et al. Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial. BMJ 2022;379:e072623.
PMID: 36520715